Company intelligence / Profile preview
Immunoah Therapeutics, Inc.
Aurora, Colorado, USAzoominfo.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Immunoah Therapeutics is developing novel agonist monoclonal antibodies for cancer immunotherapy. Lead candidates have demonstrated potent immunological enhancement and anticancer effects in preclinical studies. At least three programs have entered Phase 1 clinical trials targeting solid tumors and advanced malignancies.[3][6] The company has outlicensed rights to some assets in China.[6]
- Therapeutic areas
- Oncology
- Modalities
- Monoclonal antibodies (mAbs)Bispecific T-cell engagers (BiTEs)Bispecific antibodiesTrispecific T-cell engagers (TriTEs)[3][6]
- Industry
- Biotech
02
Drug pipeline
12 assets11 more assets in the full pipeline.
Request access →03
Partnerships
Rights to lead product candidate Zymwolumab were licensed out in China to a pharmaceutical partner in 2017.[6]Actively seeking further collaborations at all levels.[1]
Beyond the preview
Go deeper on Immunoah Therapeutics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immunoah Therapeutics, Inc..